Sort   by:  
 Page size 
UnknownSARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study.
Not available
S-EPMC8359640 | biostudies-literature
UnknownSARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study.
Not available
S-EPMC8142667 | biostudies-literature
UnknownMortality, neurodevelopmental impairments, and economic outcomes after invasive group B streptococcal disease in early infancy in Denmark and the Netherlands: a national matched cohort study.
Not available
S-EPMC8131199 | biostudies-literature
UnknownRoutine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection.
Not available
S-EPMC7367673 | biostudies-literature
UnknownA review of the costs of delivering maternal immunisation during pregnancy.
Not available
S-EPMC7482437 | biostudies-literature
UnknownThe benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study.
Not available
S-EPMC12818683 | biostudies-literature
UnknownEstimation of country-level incidence of early-onset invasive Group B Streptococcus disease in infants using Bayesian methods.
Not available
S-EPMC8202927 | biostudies-literature
UnknownNeurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina.
Not available
S-EPMC9142788 | biostudies-literature
UnknownWhat, how and who: Cost-effectiveness analyses of COVID-19 vaccination to inform key policies in Nigeria.
Not available
S-EPMC10032534 | biostudies-literature
UnknownCOVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
Not available
S-EPMC8523052 | biostudies-literature
Sort   by:  
 Page size